{"id":220265,"date":"2025-09-12T07:14:13","date_gmt":"2025-09-12T07:14:13","guid":{"rendered":"https:\/\/www.europesays.com\/us\/220265\/"},"modified":"2025-09-12T07:14:13","modified_gmt":"2025-09-12T07:14:13","slug":"beta-blockers-may-not-benefit-heart-attack-survivors","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/220265\/","title":{"rendered":"Beta Blockers May Not Benefit Heart Attack Survivors"},"content":{"rendered":"<p>Beta-blockers have had a 40-year reign as the standard treatment for heart attack patients. That may come to an end, based on the results of two new studies.<\/p>\n<p>An estimated 80 percent of people who experience a mild <a>heart attack<\/a> without lasting heart damage are prescribed beta-blockers, which block the effects of adrenaline in the body to lower blood pressure and heart rate. But an international study published Aug. 30 in The New England Journal of Medicine found that <a data-overlay-msg=\"AARP.Everywhere.LeavingModal.drawOverlay(this,&#039;&#039;,\/content\/dam\/content-fragments\/aarp-org\/en\/article\/health\/drugs-supplements\/2025\/beta-blocker-effectiveness.html,&#039;&#039;,&#039;You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.&#039;);return false;\" data-default-element-msg=\"AARP.Everywhere.LeavingModal.drawOverlay(this,&#039;&#039;,\/content\/dam\/content-fragments\/aarp-org\/en\/article\/health\/drugs-supplements\/2025\/beta-blocker-effectiveness.html,&#039;&#039;,&#039;You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.&#039;);return false;\" data-displayoverlay=\"displayOverlay\" title=\"Beta-Blockers after Myocardial Infarction\" rel=\"noreferrer noopener\" href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2504735\" target=\"_blank\">the medication offered no benefit to these patients<\/a>.<\/p>\n<p>What\u2019s more, women who take beta-blockers may have an increased risk of other complications, like death, another heart attack or hospitalization for <a href=\"https:\/\/www.aarp.org\/videos\/health\/6319368873112\/\" target=\"_blank\" data-overlay-msg=\"AARP.Everywhere.LeavingModal.drawOverlay(this,&#039;&#039;,\/content\/dam\/content-fragments\/aarp-org\/en\/article\/health\/drugs-supplements\/2025\/beta-blocker-effectiveness.html,&#039;&#039;,&#039;You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.&#039;);return false;\" title=\"heart failure video\" rel=\"noreferrer noopener\">heart failure<\/a>, the researchers found.<\/p>\n<p>Dr. Borja Ib\u00e1\u00f1ez, the study\u2019s principal investigator and scientific director of Spain\u2019s Centro Nacional de Investigaciones Cardiovasculares, said in a news release that the findings \u201crepresent one of the most significant advances in heart attack treatment in decades\u201d and could change how doctors treat many patients in the future.<\/p>\n<p>The study was conducted in patients \u201ctreated according to modern standards of care,\u201d Ib\u00e1\u00f1ez told AARP. These standards include quickly restoring blood flow to the heart after a blockage, opening all blocked arteries through surgery and using <a href=\"https:\/\/www.aarp.org\/health\/conditions-treatments\/high-blood-pressure-treatments\/\" data-overlay-msg=\"AARP.Everywhere.LeavingModal.drawOverlay(this,&#039;&#039;,\/content\/dam\/content-fragments\/aarp-org\/en\/article\/health\/drugs-supplements\/2025\/beta-blocker-effectiveness.html,&#039;&#039;,&#039;You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.&#039;);return false;\" title=\"high blood pressure treatment\" target=\"_blank\" rel=\"noopener\">medications to lower blood pressure<\/a> and prevent blood clots.<\/p>\n<p>Older adults are more likely to experience a heart attack than their younger peers. For men, heart attack risk increases around the age of 45; for women, it rises around 55.<\/p>\n<p>            <b>A closer look at the study<\/b><\/p>\n<p>The study, conducted in Spain and Italy, involved 8,4\ufeff38 patients who had experienced a heart attack but had preserved heart function, meaning the heart still pumps effectively. About h\ufeffalf of the study participants received beta-blocker therapy, and the other half used other treatments commonly prescribed to heart attack patients.<\/p>\n<p>Participants attended four follow-up appointments within the same time frame to track their vitals and statistics. The results showed that there was no significant difference in death rates, recurrent heart attack or hospitalization or heart failure between the two groups.\u00a0<\/p>\n<p>\u201cAnother important practical finding is that the abrupt withdrawal of beta-blockers in these patients does not carry safety concerns, which has clear clinical relevance,\u201d Ib\u00e1\u00f1ez said.<\/p>\n","protected":false},"excerpt":{"rendered":"Beta-blockers have had a 40-year reign as the standard treatment for heart attack patients. That may come to&hellip;\n","protected":false},"author":3,"featured_media":220266,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[120032,120031,120033,210,14036,14464,1060,67,132,68],"class_list":{"0":"post-220265","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-beta-blocker-effectiveness","9":"tag-beta-blockers","10":"tag-do-beta-blockers-work","11":"tag-health","12":"tag-heart-attacks","13":"tag-heart-health","14":"tag-medication","15":"tag-united-states","16":"tag-unitedstates","17":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115190095803226419","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/220265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=220265"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/220265\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/220266"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=220265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=220265"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=220265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}